RAD 202 receives approval to start Phase 1 therapeutic trial

0 Min Read Investing

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com